Target intelligence / Profile preview

SOX2 promoter G-quadruplex (SOX2-G4)

Target
SOX2-G4
Molecular classification
G-quadruplex, Non-canonical DNA structure, Transcriptional regulatory element
01

Overview

The SOX2 promoter G-quadruplex (SOX2-G4) is a non-canonical DNA secondary structure located within the regulatory region of the SRY-box transcription factor 2 (SOX2) gene. This specific structure belongs to the Pu27 family of G-quadruplexes, which are characterized by high sequence homology to the well-studied Pu27 silencer element in the c-MYC promoter (1.2.1, 1.3.1). In its folded state, the SOX2-G4 acts as a transcriptional repressor, and its stabilization by small molecules or specific ligands leads to the downregulation of SOX2 expression (1.4.2). SOX2 is a master regulator of pluripotency and self-renewal in both embryonic stem cells and cancer stem cells (CSCs), making this G-quadruplex an attractive therapeutic target for various malignancies, including glioblastoma, breast cancer, and leukemia (1.1.2, 1.4.5). Targeting the SOX2-G4 with ligands such as triplex metallohelices or Pu27-homologous oligonucleotides has been shown to reduce tumor initiation and viability by depleting the CSC population (1.4.2, 1.3.5). However, therapeutic challenges include achieving selectivity over other genomic G-quadruplexes and avoiding toxicity in normal stem cell niches where SOX2 function is essential (1.5.3, 1.5.4).

Other names
SOX2-Pu27-HSPu3+SOX2 promoter Pu27-homologous sequenceSOX2-G4 structure
02

Mechanism of action

Stabilization of the G-quadruplex structure within the SOX2 promoter leads to transcriptional repression of the SOX2 gene, thereby inhibiting the maintenance and proliferation of cancer stem cells.

03

Biological functions

Transcriptional regulationStem cell maintenanceSelf-renewalPluripotency maintenance
04

Disease associations

CancerGlioblastomaBreast cancerLeukemiaMelanoma
05

Safety considerations

Off-target stabilization of other genomic G-quadruplexes (e.g., c-MYC, hTERT)Potential toxicity to normal somatic stem cells (e.g., neural stem cells)Induction of genomic instability
06

Interacting drugs

[Fe2LΔ-f3]4+ (Δ-f)

3 more in the full profile.

07

Biomarkers

SOX2 expression levelsG-quadruplex formation (BG4 antibody)CD133Nestin

Beyond the preview

Go deeper on SOX2 promoter G-quadruplex (SOX2-G4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SOX2 promoter G-quadruplex (SOX2-G4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call